logo

AFJK

Aimei Health·NASDAQ
--
--(--)
--
--(--)
3.71 / 10
Netural

Aimei Health's fundamental score is 3.7/10, indicating weak quality. Key bullish factors are strong operating revenue growth (92.79% YoY) and a healthy gross profit margin (36.70%). However, significant concerns include negative net income-to-revenue (-0.1516), low return on total assets (-0.9811), and high current liabilities relative to total liabilities (80.08%). These imbalances suggest limited profitability and higher leverage risk, supporting a defensive stance.

Fundamental(3.71)SentimentTechnical

Analysis Checks(4/10)

Gross profit margin (%)
Value36.70
Score2/3
Weight9.61%
1M Return1.53%
Current liabilities / Total liabilities (%)
Value80.08
Score3/3
Weight32.50%
1M Return4.95%
Net income-Revenue
Value-0.15
Score1/3
Weight2.92%
1M Return0.49%
Basic earnings per share (YoY growth rate %)
Value-35.76
Score0/3
Weight2.99%
1M Return0.50%
Rate of return on total assets (%)
Value-0.98
Score1/3
Weight8.94%
1M Return1.48%
Total profit / EBIT (%)
Value-164.34
Score3/3
Weight13.06%
1M Return2.19%
Annualized return on total assets (%)
Value-1.31
Score1/3
Weight8.94%
1M Return1.48%
Diluted earnings per share (YoY growth rate %)
Value-35.76
Score0/3
Weight5.22%
1M Return0.88%
Operating revenue (YoY growth rate %)
Value92.79
Score2/3
Weight16.93%
1M Return2.60%
Asset-MV
Value-0.51
Score1/3
Weight-1.11%
1M Return-0.20%
Is AFJK undervalued or overvalued?
  • AFJK scores 3.71/10 on fundamentals and holds a Fair valuation at present. Backed by its 1.68% ROE, 0.00% net margin, 211.03 P/E ratio, 7.06 P/B ratio, and -78.46% earnings growth, these metrics solidify its Netural investment rating.